FRANCISCO JAVIER
MICHEL DE LA ROSA
Researcher to 2022
Hospital de Jerez
Jerez, EspañaPublications in collaboration with researchers from Hospital de Jerez (1)
2023
-
First-Line Versus Second-Line Use of Reslizumab in Severe Uncontrolled Asthma
Journal of Investigational Allergology and Clinical Immunology